BPA Call FA301021A0005-FA301021FG018
Award Date 5/3/21
Potential Completion Date 9/30/21
Potential Value $23K
Federal Agency
Awardee
Ultimate Awardee
NAICS Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Santa Clara, CA 95054, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Department of the Air Force Air Education and Training Command awarded a $13,557 firm fixed price blanket purchase agreement call contract to Abbott Laboratories, Division Abbott Vascular Inc. for medical and surgical instruments, equipment, and supplies. Abbott Laboratories, a subsidiary of Abbott Laboratories, will deliver the requested products to support operations at Santa Clara, California. No set-aside provisions were specified. The completion date is September 30, 2023, allowing over...
- Abbott Laboratories, through its division Abbott Vascular Inc., was awarded a $27,471 firm fixed price blanket purchase agreement call for the delivery of surgical equipment to Keesler Air Force Base. The Department of the Air Force Air Education and Training Command issued the call under an existing BPA for medical supplies and equipment to support training and operations at its installations. Per the award details, Abbott will provide the requested surgical items to the Air Force medical...
- This is a federal contract award to Abbott Laboratories Inc., through its Abbott Diagnostics Division, for the provision of medical and surgical instruments, equipment, and supplies. The contract has a ceiling value of $90,893.50 and was awarded by the Air Mobility Command, a component of the U.S. Department of Defense. The contract is a Blanket Purchase Agreement (BPA) call, with a firm fixed-price pricing type, and has an ultimate completion date of September 30, 2020. The contract does not...
- The Defense Health Agency awarded Abbott Laboratories, through its division Abbott Vascular Inc., a $300,000 blanket purchase agreement for medical instruments and supplies. As the parent company, Abbott Laboratories will deliver the requested products to support DHA operations through May 2021 under the terms of this BPA call contract, which utilizes firm fixed pricing. Located in Santa Clara, California, Abbott Vascular Inc. will perform under the contract without a set-aside designation. This...
- Abbott Laboratories Abbott Vascular Inc. Division was awarded a $36,888.08 firm fixed price blanket purchase agreement (BPA) call contract by the Department of Defense Army Medical Command to provide various cardiac implants and supplies. Performance will occur in Santa Clara, California under this six-month contract set to run from March 4, 2020 through September 30, 2020. As the prime contractor, Abbott Laboratories Abbott Vascular Inc. Division will deliver the requested cardiac devices and...
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, was awarded a fixed-price delivery order valued at $25,715.85 by the Defense Logistics Agency's Medical Supply Chain on September 5, 2025, with an ultimate completion date of September 15, 2025. The contract, which carries no set-aside designation and reflects full and open competition, is for delivery to Santa Clara, California. This delivery order represents a task order against Abbott's existing Indefinite Delivery...
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, was awarded a fixed-price delivery order (Contract No. 4568634478, GALLANT) by the Medical Supply Chain division of the Department of Defense on June 20, 2025, with an ultimate completion date of June 25, 2025. The contract, valued at $30,281.95, carries no set-aside designation, indicating full and open competition. Performance will occur at Abbott's facility in Santa Clara, California. This delivery order represents a...
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, has been awarded a fixed-price delivery order valued at $5,695.00 by the Defense Logistics Agency's Medical Supply Chain division. The contract, issued on May 20, 2025, with an ultimate completion date of June 9, 2025, represents a child contract under Abbott Laboratories Inc.'s parent entity and will be performed in Santa Clara, California. This delivery order was awarded without a set-aside designation, indicating full and...
- The Department of Veterans Affairs awarded Abbott Laboratories, through its Abbott Vascular Inc. division, a $2.5 million firm fixed price delivery order contract to provide medical products and services. As the prime contractor, Abbott Laboratories will draw from its parent company Abbott Laboratories' expertise in healthcare to support the VA's efforts improving care for veterans. Performance will take place in Santa Clara, California through December 2024. No subcontractors or set aside...
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, was awarded a delivery order (Contract No. 4569302326) valued at $9,243.00 by the Defense Logistics Agency's Medical Supply Chain on August 21, 2025, with an ultimate completion date of September 8, 2025. The contract utilizes fixed-price pricing with economic price adjustment and does not include a set-aside designation, indicating full and open competition. Performance will take place in Santa Clara, California. This delivery...
- FA301021A0005Blanket Purchase Agreement
- FA301021A0005-FA301021FG018BPA Call
The Department of the Air Force Air Education and Training Command awarded Abbott Laboratories, through its division Abbott Vascular Inc., a $23,351 firm fixed price call against a blanket purchase agreement for medical and surgical instruments, equipment, and supplies. Abbott Laboratories, headquartered in Santa Clara, California, will provide the products to support Air Force training and medical needs under the contract, which has a period of performance through September 30, 2021. No set-aside provisions were applied to this award to the major medical device manufacturer.
Generated 1/3/24, 12:15 PM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $23.4k | 4/21/21 |